121 related articles for article (PubMed ID: 19119788)
1. [Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years].
Fernández-Ruiz M; Guerra-Vales JM; Llenas-García J; Colina-Ruizdelgado F
Rev Esp Enferm Dig; 2008 Oct; 100(10):625-31. PubMed ID: 19119788
[TBL] [Abstract][Full Text] [Related]
2. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
[TBL] [Abstract][Full Text] [Related]
3. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of clinical characteristics of non-B non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma and prognosis in Uighur patients].
Zhang R; Zhou S; Xiao L; Zhang H; Tulahong A; Zhang Y; Wen H; Bao Y
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):540-4. PubMed ID: 26463333
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
7. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
Shin BS; Park MH; Jeon GS
Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
[TBL] [Abstract][Full Text] [Related]
10. Treatment and prognostic factors in patients with hepatocellular carcinoma.
Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
[TBL] [Abstract][Full Text] [Related]
11. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Lladó L; Virgili J; Figueras J; Valls C; Dominguez J; Rafecas A; Torras J; Fabregat J; Guardiola J; Jaurrieta E
Cancer; 2000 Jan; 88(1):50-7. PubMed ID: 10618605
[TBL] [Abstract][Full Text] [Related]
12. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
13. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
15. Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
Mahady SE; Charlton B; Fitzgerald P; Koorey DJ; Perry JF; Waugh RC; McCaughan GW; Strasser SI
J Gastroenterol Hepatol; 2010 Jul; 25(7):1299-305. PubMed ID: 20594260
[TBL] [Abstract][Full Text] [Related]
16. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
Ollivier I; Dauvois B; Guittet L; Boutreux S; Dupont B; Launoy G; Dao T
Gastroenterol Clin Biol; 2010; 34(4-5):288-96. PubMed ID: 20189339
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years.
Kim YJ; Jang BK; Kim ES; Chung WJ; Park KS; Cho KB; Hwang JS
J Korean Med Sci; 2012 Oct; 27(10):1147-54. PubMed ID: 23091310
[TBL] [Abstract][Full Text] [Related]
18. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
Jia L; Kiryu S; Watadani T; Akai H; Yamashita H; Akahane M; Ohtomo K
Acta Med Okayama; 2012; 66(2):131-41. PubMed ID: 22525471
[TBL] [Abstract][Full Text] [Related]
20. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
